XML 42 R31.htm IDEA: XBRL DOCUMENT v3.24.4
Shareholders’ Deficit (Tables)
9 Months Ended
Nov. 30, 2024
Shareholders’ Deficit [Abstract]  
Schedule of Stock Option Activity A summary of the Company’s stock option activity for the nine-months ended November 30, 2024, is as follows:
(amounts in thousands, except share and per share data)  Number of
Options
   Exercise
Price
   Weighted
Average
Intrinsic
Value
 
Outstanding, February 29, 2024   4,250,000   $0.37   $
       -
 
Granted   4,000,000    0.50    
-
 
Exercised   
-
    
-
    
-
 
Cancelled   
-
    
-
    
-
 
Outstanding, November 30, 2024   8,250,000   $0.37   $
-
 
Schedule of Exercise Prices and Information Related to Options The exercise prices and information related to options under the 2011 Plan outstanding on November 30, 2024 is as follows:
Range of
Exercise Price
   Stock Options
Outstanding
   Stock Options
Exercisable
   Weighted
Average
Remaining
Contractual
Life
   Weighted
Average
Exercise Price
of Options
Outstanding
   Weighted
Average
Exercise Price
of Options
Exercisable
 
$0.25 to $.50    8,250,000    8,250,000    5.06   $0.43   $0.43 
The exercise prices and information related to the warrants as of November 24, 2024, is as follows:
Range of
Exercise Price
   Stock Warrants
Outstanding
   Stock Warrants
Exercisable
   Weighted
Average
Remaining
Contractual
Life
   Weighted
Average
Exercise Price
of Warrants
Outstanding
   Weighted
Average
Exercise Price
of Warrants Exercisable
 
$0.50    3,511,664    3,511,664    6.13   $0.50    0.50 
$1.00    3,000,000    3,000,000    2.43   $1.00   $1.00 
Schedule of Warrant Activity A summary of the Company’s warrant activity for the nine-months ended November 30, 2024, is as follows:
   Number of
Warrants
   Weighted
Average Exercise
Price
 
Outstanding, February 29, 2024   3,521,664   $0.83 
Granted   3,000,000    1.00 
Exercised   
-
    
-
 
Cancelled   (10,000)   1.40 
Outstanding, November 30, 2024   6,511,664   $0.73